Definium Therapeutics, Inc. ($DFTX)
Filing Information
| Accession Number | 0001193125-26-384042 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 5, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
59,023
Total Value
$721,732.62
P&L
+inf% (+$1,523,600.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Shares | โ | Sep 2, 2026 | Grant/Award | 40,000 | $0.00 | $0.00 | 1,513,663 | Direct | โ | View Details | |
Director | Common Shares | โ | Sep 3, 2026 | Sale | 19,023 | $37.94 | $721,732.62 | 1,494,640 | Direct | โ | View Details |